Company Meets Goal For SARS Vaccine |
|
|
|
|
Written by Scott Cosby
|
|
Wednesday, 27 June 2007 |
|
Lipid Sciences Incorporated has recently reported to the National Institutes of Health (NIH) that it has met a study goal of creating a vaccine preparation for Severe Acute Respiratory Syndrome (SARS).
The company demonstrated that by modifying viral particles could be used in preparation of a preventive vaccine against the SARS.
The research project was performed at Meharry Medical College in Nashville, Tennessee.
Tags:
Click to add your tags...,
| Comments () >> |
 |
| Write comment |
You must be logged in to a comment. Please register if you do not have an account yet. |
|